These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 9153522
1. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522 [Abstract] [Full Text] [Related]
2. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, Konishi J, Kimura J. Arch Neurol; 1998 May; 55(5):609-14. PubMed ID: 9605717 [Abstract] [Full Text] [Related]
3. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Nagahama Y, Fukuyama H, Turjanski N, Kennedy A, Yamauchi H, Ouchi Y, Kimura J, Brooks DJ, Shibasaki H. Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049 [Abstract] [Full Text] [Related]
4. Corpus callosum size in children with spastic cerebral palsy: relationship to clinical outcome. Kułak W, Sobaniec W, Kubas B, Walecki J. J Child Neurol; 2007 Apr; 22(4):371-4. PubMed ID: 17621513 [Abstract] [Full Text] [Related]
5. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Goffinet AM, De Volder AG, Gillain C, Rectem D, Bol A, Michel C, Cogneau M, Labar D, Laterre C. Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043 [Abstract] [Full Text] [Related]
6. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, Kimura J, Konishi J. Arch Neurol; 1993 Oct; 50(10):1070-4. PubMed ID: 8215966 [Abstract] [Full Text] [Related]
7. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, Konishi J, Shio H. J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614 [Abstract] [Full Text] [Related]
8. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Josephs KA, Tang-Wai DF, Edland SD, Knopman DS, Dickson DW, Parisi JE, Petersen RC, Jack CR, Boeve BF. Arch Neurol; 2004 Dec; 61(12):1881-4. PubMed ID: 15596608 [Abstract] [Full Text] [Related]
9. Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Arch Neurol; 1996 Nov; 53(11):1103-9. PubMed ID: 8912483 [Abstract] [Full Text] [Related]
11. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227 [Abstract] [Full Text] [Related]
12. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. Giordano A, Tessitore A, Corbo D, Cirillo G, de Micco R, Russo A, Liguori S, Cirillo M, Esposito F, Tedeschi G. Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861 [Abstract] [Full Text] [Related]
13. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574 [Abstract] [Full Text] [Related]
14. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Lehéricy S, Hartmann A, Lannuzel A, Galanaud D, Delmaire C, Bienaimée MJ, Jodoin N, Roze E, Gaymard B, Vidailhet M. Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434 [Abstract] [Full Text] [Related]
15. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI. Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337 [Abstract] [Full Text] [Related]
16. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Sydykova D, Stahl R, Dietrich O, Ewers M, Reiser MF, Schoenberg SO, Möller HJ, Hampel H, Teipel SJ. Cereb Cortex; 2007 Oct; 17(10):2276-82. PubMed ID: 17164468 [Abstract] [Full Text] [Related]
17. Effects of white matter lesions and lacunes on cortical function. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Arch Neurol; 2004 Oct; 61(10):1545-50. PubMed ID: 15477508 [Abstract] [Full Text] [Related]
18. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Appenzeller S, Rondina JM, Li LM, Costallat LT, Cendes F. Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703 [Abstract] [Full Text] [Related]
19. Corpus callosum atrophy is associated with gait disorders in patients with leukoaraiosis. Moretti M, Carlucci G, Di Carlo A, Fonda C, Prieto M, Mugnai S, Bracco L, Piccini C, Pracucci G, Inzitari D. Neurol Sci; 2005 Jun; 26(2):61-6. PubMed ID: 15995821 [Abstract] [Full Text] [Related]
20. Marchiafava-Bignami disease: literature review and case report. Kohler CG, Ances BM, Coleman AR, Ragland JD, Lazarev M, Gur RC. Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jan; 13(1):67-76. PubMed ID: 10645739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]